Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tracheal disorder
Clinical narrative: HCP indicated tracheitis; Less of a passageway; Fair amount of coughing/Dry cough; Swelling in the neck area; Fatigue; Is there any correlation between the delated anaphylaxis and ingredient?; Throat tightening with difficulty breathing; Throat tightening with difficulty breathing; This is a spontaneous report received from a contactable consumer (reported for himself). A 40-years-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EW0164) administered in left deltoid via an unknown route of administration on 16Apr2021 at 12:50 pm as 1st dose single for COVID-19 immunization. It was reported that that he received the vaccine in his left arm, the bicep muscle, or above the bicep. He states the muscle on the shoulder area. Patient states that asthma was in the lungs and chest. He has had mild intermittent asthma and gets it 4 times a year. There was no prior Vaccinations, no adverse events within 4 weeks. Medical history included asthma (patient was diagnosed 30 years ago), allergic to shellfish. The patient's concomitant medications were not reported. On 16Apr2021 patient experienced is there any correlation between the delated anaphylaxis and ingredient, throat tightening with difficulty breathing (Throat tightness and dyspnea), less of a passageway, fair amount of coughing/dry cough swelling in the neck area and fatigue. On 19Apr2021 at 10:15 HCP indicated tracheitis. The patient states that he got the vaccine on 16Apr2021 at 12:50 pm and isn't sure exactly when the swelling started because he got a little fatigued. Patient states that it was about 3-5 hours after and at a certain point he noticed it. It was reported that a half an hour to an hour later patient throat started to tighten, it gets triggered by certain stimuli, steam and vocalization, and rubbing the area. patient states that he could reproduce the issue if he rubs the area, the frequency has decreased, and in that case, it has improved. It was reported that patient was diagnosed with tracheitis on 19Apr2021 at 10:15 and it was still ongoing, or the effects of it are. Patient states that what he feels in the front of his throat near the trachea and up a little further was inflammation. Patient gets the symptoms of the tightening of the throat, and it is inflamed there is less area to breath. Patient states that his understanding of the tightening of the throat and dry cough are all symptoms of the tracheitis. It was reported that the first symptom experienced after the injection (at least 2-3 -4 hours), patient had fatigue first then probably a half an hour to an hour later the swelling started. patient believes the fatigue has gone away, but not 100 percent sure. patient states that there are times he has felt fatigue and is not 100 percent of the cause. patient states that if he does feel fatigue, he assumes it because of the tracheitis. patient states that these events happen when he needs to get area in his throat, and it might cause the fatigue. patient states that the coughing is parallel with the throat tightening, when he wants to open his airway or pass way the coughing seems to occur. Patient states he gets relief or a more open passageway and the coughing reflex or coughing bouts are less, when he gets the tightness of the throat or the inflammation he sort of goes into coughing. The outcome of the event for hcp indicated tracheitis was not recovered and unknown for the other events, whereas the outcome of the event fatigue was recovered.   Follow up were needed, further information has been requested.  07May2021: Follow-up spontaneous report received from a contactable consumer. No new information was reported.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021524696 Pfizer